ALVO
Price
$4.79
Change
-$0.34 (-6.63%)
Updated
Oct 22 closing price
Capitalization
1.71B
20 days until earnings call
Intraday BUY SELL Signals
LFCR
Price
$6.37
Change
-$0.00 (-0.00%)
Updated
Oct 22 closing price
Capitalization
241.12M
15 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ALVO vs LFCR

ALVO vs LFCR Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ALVO vs. LFCR commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALVO is a Hold and LFCR is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ALVO with price predictions
Oct 22, 2026

ALVO's Stochastic Oscillator sits in oversold zone for 8 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a +1.99% 3-day Advance, the price is estimated to grow further. Considering data from situations where ALVO advanced for three days, in 199 of 272 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.

The Aroon Indicator entered an Uptrend today. In 117 of 166 cases where ALVO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 70%.

Bearish Trend Analysis

The 10-day RSI Indicator for ALVO moved out of overbought territory on September 29, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In 22 of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at 85%.

The Momentum Indicator moved below the 0 level on October 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ALVO as a result. In 62 of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 63%.

The Moving Average Convergence Divergence Histogram (MACD) for ALVO turned negative on September 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 36 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 78%.

ALVO moved below its 50-day moving average on October 16, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for ALVO crossed bearishly below the 50-day moving average on October 22, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALVO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.

ALVO broke above its upper Bollinger Band on September 18, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 10 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-8.926) is normal, around the industry mean (10.407). P/E Ratio (-7.726) is within average values for comparable stocks, (-6.173). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.037) among similar stocks. P/S Ratio (3.071) is also within normal values, averaging (178.797).

The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. ALVO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 97 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALVO’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

A.I.Advisor
a Summary for LFCR with price predictions
Oct 22, 2026

LFCR in downward trend: price expected to drop as it breaks its higher Bollinger Band on September 28, 2026

LFCR broke above its upper Bollinger Band on September 28, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options. The A.I.dvisor looked at 40 similar instances where the stock broke above the upper band. In 32 of the 40 cases the stock fell afterwards. This puts the odds of success at 80%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 18 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Momentum Indicator moved below the 0 level on October 12, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on LFCR as a result. In 72 of 91 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 79%.

The Moving Average Convergence Divergence Histogram (MACD) for LFCR turned negative on October 15, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 32 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 71%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where LFCR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 79%.

The Aroon Indicator for LFCR entered a downward trend on September 21, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

LFCR moved above its 50-day moving average on September 28, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for LFCR crossed bullishly above the 50-day moving average on September 28, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.

Following a +56.90% 3-day Advance, the price is estimated to grow further. Considering data from situations where LFCR advanced for three days, in 207 of 269 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. LFCR’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 61 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-7.072) is normal, around the industry mean (10.407). P/E Ratio (-5.016) is within average values for comparable stocks, (-6.173). Projected Growth (PEG Ratio) (2.661) is also within normal values, averaging (2.152). Dividend Yield (0.000) settles around the average of (0.037) among similar stocks. P/S Ratio (1.222) is also within normal values, averaging (178.797).

The Tickeron PE Growth Rating for this company is 81 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. LFCR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 83, placing this stock worse than average.

FUNDAMENTALS RATINGS
ALVO vs LFCR: Fundamental Ratings
ALVO
LFCR
OUTLOOK RATING
1..100
7564
VALUATION
overvalued / fair valued / undervalued
1..100
10
Undervalued
61
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
4036
P/E GROWTH RATING
1..100
9781
SEASONALITY SCORE
1..100
75n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALVO's Valuation (10) in the null industry is somewhat better than the same rating for LFCR (61) in the Industrial Specialties industry. This means that ALVO’s stock grew somewhat faster than LFCR’s over the last 12 months.

ALVO's Profit vs Risk Rating (100) in the null industry is in the same range as LFCR (100) in the Industrial Specialties industry. This means that ALVO’s stock grew similarly to LFCR’s over the last 12 months.

ALVO's SMR Rating (100) in the null industry is in the same range as LFCR (100) in the Industrial Specialties industry. This means that ALVO’s stock grew similarly to LFCR’s over the last 12 months.

LFCR's Price Growth Rating (36) in the Industrial Specialties industry is in the same range as ALVO (40) in the null industry. This means that LFCR’s stock grew similarly to ALVO’s over the last 12 months.

LFCR's P/E Growth Rating (81) in the Industrial Specialties industry is in the same range as ALVO (97) in the null industry. This means that LFCR’s stock grew similarly to ALVO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALVOLFCR
RSI
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
73%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
73%
Bullish Trend 1 day ago
79%
Momentum
ODDS (%)
Bearish Trend 1 day ago
63%
Bearish Trend 1 day ago
79%
MACD
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
71%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
78%
Bullish Trend 1 day ago
78%
Advances
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 24 days ago
77%
Declines
ODDS (%)
Bearish Trend 9 days ago
79%
Bearish Trend 10 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
68%
Bearish Trend 1 day ago
80%
Aroon
ODDS (%)
Bullish Trend 1 day ago
70%
Bearish Trend 2 days ago
78%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (ALVO: $4.79 vs. LFCR: $6.37)
Brand notoriety: ALVO and LFCR are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: ALVO: 78% vs. LFCR: 60%
Market capitalization -- ALVO: $1.71B vs. LFCR: $241.12M
ALVO [@Pharmaceuticals: Generic] is valued at $1.71B. LFCR’s [@Pharmaceuticals: Generic] market capitalization is $241.12M. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $2.12K to $68.49B. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $4.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALVO’s FA Score shows that 1 FA rating(s) are green while LFCR’s FA Score has 0 green FA rating(s).

  • ALVO’s FA Score: 1 green, 4 red.
  • LFCR’s FA Score: 0 green, 5 red.
According to our system of comparison, ALVO is a better buy in the long-term than LFCR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALVO’s TA Score shows that 4 TA indicator(s) are bullish while LFCR’s TA Score has 4 bullish TA indicator(s).

  • ALVO’s TA Score: 4 bullish, 6 bearish.
  • LFCR’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, both ALVO and LFCR are a bad buy in the short-term.

Price Growth

ALVO (@Pharmaceuticals: Generic) experienced а -9.79% price change this week, while LFCR (@Pharmaceuticals: Generic) price change was -0.78% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was -3.00%. For the same industry, the average monthly price growth was -9.86%, and the average quarterly price growth was +9.31%.

Reported Earning Dates

ALVO is expected to report earnings on Nov 11, 2026.

LFCR is expected to report earnings on Nov 06, 2026.

Industries' Descriptions

@Pharmaceuticals: Generic (-3.00% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

View a ticker or compare two or three
ALVO
Daily Signal:
Gain/Loss:
LFCR
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

ALVO and

Correlation & Price change

A.I.dvisor tells us that ALVO and CRON have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ALVO and CRON's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALVO
1D Price
Change %
ALVO100%
-6.63%
CRON - ALVO
24%
Poorly correlated
+1.62%
EBS - ALVO
23%
Poorly correlated
+0.48%
PAHC - ALVO
22%
Poorly correlated
+1.43%
ACB - ALVO
22%
Poorly correlated
+0.25%
LFCR - ALVO
21%
Poorly correlated
N/A
More

LFCR and

Correlation & Price change

A.I.dvisor tells us that LFCR and SHPH have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that LFCR and SHPH's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LFCR
1D Price
Change %
LFCR100%
N/A
SHPH - LFCR
31%
Poorly correlated
-4.36%
COLL - LFCR
28%
Poorly correlated
+2.55%
PAHC - LFCR
27%
Poorly correlated
+1.43%
TLRY - LFCR
27%
Poorly correlated
+0.34%
VTRS - LFCR
25%
Poorly correlated
+0.16%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAG15.071.03
+7.34%
Conagra Brands
CCAP8.760.26
+3.06%
Crescent Capital BDC
TRAX43.140.37
+0.87%
First Tracks Biotherapeutics Inc.
MUFG21.41-0.36
-1.65%
Mitsubishi UFJ Financial Group
NA1.68-0.16
-8.70%
Nano Labs Ltd